CLINICAL-PHARMACOLOGY OF TRIMETREXATE

被引：17

作者：

HO, DHW

COVINGTON, WP

LEGHA, SS

NEWMAN, RA

KRAKOFF, IH

机构：

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1987年 / 42卷 / 03期

关键词：

D O I：

10.1038/clpt.1987.160

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：351 / 356

页数：6

共 24 条

[1]

BALIS FM, 1986, CANCER RES, V46, P169

[2]

BALIS FM, 1985, P AM SOC CLIN ONCOL, V4, P35

[3] ESTRIP, A BASIC COMPUTER-PROGRAM FOR OBTAINING INITIAL POLYEXPONENTIAL PARAMETER ESTIMATES [J].

BROWN, RD ;

MANNO, JE .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1978, 67 (12) :1687-1691

[4]

DIDDENS H, 1983, CANCER RES, V43, P5286

[5] DRUG METABOLISM AFTER REPEATED TREATMENTS WITH CYTOTOXIC AGENTS [J].

DONELLI, MG ;

GARATTINI, S .

EUROPEAN JOURNAL OF CANCER, 1971, 7 (04) :361-+

[6]

GIBALDI M, 1974, PHARMACOKINETICS, P281

[7] ENZYMATIC ASSAYS FOR 2,4-DIAMINO-5-METHYL-6-[(3,4,5-TRIMETHOXYANILINO)METHYL]QUINAZOLINE, A PROMISING NEW NON-CLASSICAL ANTIFOLATE [J].

HEUSNER, JJ ;

MCCORMACK, JJ .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1981, 70 (07) :827-828

[8]

HEUSNER JJ, 1985, P AM ASSOC CANC RES, V26, P234

[9] BIOCHEMICAL PHARMACOLOGY OF THE LIPOPHILIC ANTIFOLATE, TRIMETREXATE [J].

JACKSON, RC ;

FRY, DW ;

BORITZKI, TJ ;

BESSERER, JA ;

LEOPOLD, WR ;

SLOAN, BJ ;

ELSLAGER, EF .

ADVANCES IN ENZYME REGULATION, 1984, 22 :187-206

[10] UPTAKE AND EFFICACY OF TRIMETREXATE (TMQ, 2,4-DIAMINO-5-METHYL-6-[(3,4,5-TRIMETHOXYANILINO)METHYL] QUINAZOLINE), A NON-CLASSICAL ANTIFOLATE IN METHOTREXATE-RESISTANT LEUKEMIA-CELLS INVITRO [J].

KAMEN, BA ;

EIBL, B ;

CASHMORE, A ;

BERTINO, J .

BIOCHEMICAL PHARMACOLOGY, 1984, 33 (10) :1697-1699

← 1 2 3 →